BIO-TECHNE Corp

TECH Nasdaq SEC CIK 842023
Follow Bio-Techne Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $299.7M +4.6% vs same quarter last year
Net income $28.3M −25.9% vs same quarter last year
EPS, diluted $0.18 −25% vs same quarter last year
Operating cash flow $73.1M +165% vs same quarter last year
Revenue by quarter
$297M
$316.2M
$317M
$286.6M
$295.9M
$311.4M
$321.2M
$299.7M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$500M$1B$1.5BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$1.2B$181.9M
FY25$1.2B$73.4M
FY24$1.2B$168.1M
FY23$1.1B$285.3M
FY22$1.1B$272.1M
FY21$931M$140.4M
FY20$738.7M$229.3M
FY19$714M$96.1M
FY18$643M$126.2M
FY17$563M$76.1M
FY16$499M$104.5M
FY15$452.2M$107.7M
FY14$357.8M$110.9M
FY13$310.6M$112.6M
FY12$314.6M$112.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2665.8%20.7%15%
FY2564.8%8.4%6%
FY2466.4%17.8%14.5%
FY2367.7%26.3%25.1%
FY2268.4%26.8%24.6%
FY2168%25.5%15.1%
FY2065.4%21.3%31%
FY1966.3%20.5%13.5%
FY1867.2%21.2%19.6%
FY1766.5%21.4%13.5%
FY1667.5%30.2%20.9%
FY1567.9%32.5%23.8%
FY1470.3%44.7%31%
FY1374.4%0.1%36.2%
FY1275%52.8%35.7%
Free cash flowOperating cash flow minus capital expenditure
$0$100M$200M$300M$400MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$263.2M
FY25$256.6M
FY24$236.1M
FY23$216.1M
FY22$280.4M
FY21$307.9M
FY20$153.5M
FY19$156.2M
FY18$149.4M
FY17$128.5M
FY16$127.3M
FY15$119.5M
FY14$122.9M
FY13$101.1M
FY12$120.7M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300M$400MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearDividendsBuybacks
FY26$49.9M$41.7M
FY25$50.4M$275.7M
FY24$50.4M$80M
FY23$50.3M$19.6M
FY22$50.2M$161M
FY21$49.6M$43.2M
FY20$48.9M$50.1M
FY19$48.4M$15.4M
FY18$48M$0
FY17$47.3M-
FY16$47.6M-
FY15$47.1M$0
FY14$45.4M$0
FY13$43.5M$1.8M
FY12$41M$23.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Bio-Techne
  • Healthcare median
−100%−50%0%50%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearBio-TechneHealthcare median
FY2615%−11.1%
FY256%−30.6%
FY2414.5%−47%
FY2325.1%−58%
FY2224.6%−80.4%
FY2115.1%−71.9%
FY2031%−62.2%
FY1913.5%−46.3%
FY1819.6%−49.6%
FY1713.5%−45.9%
FY1620.9%−36%
FY1523.8%−38.4%
FY1431%−35.5%
FY1336.2%−37.1%
FY1235.7%−29.1%